SCIENCE

Risks of Decompression Sickness and Venous Thromboembolism during Spaceflight and Patent Foramen Ovale Implications

NASATuesday, September 22, 2026 at 7:19 PM

RedScroll Brief

Risks of Decompression Sickness and Venous Thromboembolism during Spaceflight and Patent Foramen Ovale Implications — Image via NASA

NASA’s Office of the Chief Health and Medical Officer formed a working group in August 2026 to review the most recent data related to extravehicular activity (EVA) prebreathe testing and decompression sickness (DCS) events, venous thromboembolism (VTE) in-flight occurrences, and…

RedScroll Signal

Impact: High
Category: Science
Market relevance: None
Why it matters: Scientific signal separates durable discovery from noise — and often foreshadows policy and product. NASA’s Office of the Chief Health and Medical Officer formed a working group in August 2026 to review the most recent data related to extravehicular activity (EVA) prebreathe testing and decompression sickness (DCS) events, venous thromboembolism (VTE) in-flight occurrences, and…

Read original source → NASA Edition 2026-09-22

Desk copy

RedScroll Briefing

Extractive editorial brief — not a reprint of the original

What happened

Why it matters

Scientific signal separates durable discovery from noise — and often foreshadows policy and product.

Background

NASA reported on this under science. RedScroll surfaces the signal with an extractive brief — not a reprint of the original article. Read the source for full reporting.

Timeline

Tue, Sep 22, 2026, 7:19 PM UTC
NASA published: Risks of Decompression Sickness and Venous Thromboembolism during Spaceflight and Patent Foramen Ovale Implications
Now
Story is in today’s RedScroll edition. Follow the original source for updates.

Source

NASA

Original reporting by NASA. RedScroll provides an extractive briefing only.